We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
(Approval lapsed) OXYBUTYNIN CHLORIDE 5mg Tablets USP (Novitium Pharma LLC -USA)
Section 19A approved medicine
(Approval lapsed) OXYBUTYNIN CHLORIDE 5mg Tablets USP (Novitium Pharma LLC -USA)
Section 19A approval holder
Pro Pharmaceuticals Group Pty Ltd ABN: 20 605 457 430
Phone
1300 077 674
Approved until
Status
Expired
Medicines in short supply/unavailable
DITROPAN oxybutynin hydrochloride 5mg tablet - ARTG 48965
Indication(s)
Treatment of detrusor over-activity where conservative measures have failed.
Images
